First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $180.98 and last traded at $179.35, with a volume of 66514 shares changing hands. The stock had previously closed at $179.35.
First Trust NYSE Arca Biotechnology Index Fund Stock Performance
The business’s 50-day simple moving average is $171.20 and its 200 day simple moving average is $169.67. The company has a market capitalization of $1.35 billion, a P/E ratio of 17.20 and a beta of 0.86.
Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Dominguez Wealth Management Solutions Inc. acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the 3rd quarter worth approximately $201,000. Blue Trust Inc. boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 3,248.6% during the third quarter. Blue Trust Inc. now owns 1,172 shares of the company’s stock worth $202,000 after buying an additional 1,137 shares in the last quarter. J.W. Cole Advisors Inc. acquired a new position in First Trust NYSE Arca Biotechnology Index Fund in the third quarter worth approximately $203,000. Synovus Financial Corp bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the third quarter valued at $203,000. Finally, Wharton Business Group LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the third quarter valued at $206,000.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Insider Buying Explained: What Investors Need to Know
- Sizing Up a New Opportunity for NVIDIA Investors
- Stock Average Calculator
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- High Flyers: 3 Natural Gas Stocks for March 2022
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
